Abstract
Eighteen-Month Interim Analysis of Efficacy and Safety of Givosiran, an RNAi Therapeutic for Acute Hepatic Porphyria, in the Envision Open Label Extension
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have